NHS Approves Breast Cancer Drug Rejected Two Years Ago After Trump Deal Raises NICE Spending Limit
NICE has approved Enhertu for eligible women in England after a new drug deal and higher cost-effectiveness threshold made the treatment affordable for NHS funding.
International Business Times UK ·